Clinical Trial Update: Efficacy and Safety of Topical Bromfenac Ophthalmic Solution vs. Placebo in Subjects With Allergic Conjunctivitis [Phase 3]

View source ↗

Summary

A Phase 3 study comparing topical bromfenac ophthalmic solution to placebo in allergic conjunctivitis has completed, assessing efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• Bromfenac Ophthalmic Solution (bromfenac sodium)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Allergic Conjunctivitis | Phase 3 | Status: COMPLETED